Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled nebulised unfractionated heparin sodium in stable COPD
2010-024168-16Phase 2Terminated
- Sponsor
- IRCCS San Raffaele Pisana
- Start
- Mar 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of heparin in chronic obstructive pulmonary disease (COPD), sponsored by IRCCS San Raffaele Pisana. Primary endpoint: Forced expiratory volume in one second. Started Mar 2012; status: terminated.
02
Drugs
heparin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-024168-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024168-16.